Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Covid-19 - Lagos, Kano Lead As Nigeria Vaccinates Over 1m Persons

04/16/2021 | 10:06am EDT

As the national vaccination exercise against COVID-19 entered its sixth week, the federal government has said that 1,051,096 people have so far received a single dose of the Astrazeneca vaccine jab as at yesterday, Thursday, April 15, 2021.

In an update on the ongoing vaccination across the country, posted on its platform, the National Primary Healthcare Development Agency (NPHCDA), said that vaccination was being carried out in all the 36 states and the Federal Capital Territory (FCT).

The agency put the percentage of the vaccine doses so far administered at 52.2 per cent.

The statistics showed that Lagos State was leading in the number of persons vaccinated with 193,794, followed by Kano, 57,165; and Kaduna with 55,756.

The vaccination figures showed that Abia had 6,506; Adamawa, 18,964; Akwa Ibom, 11,400; Anambra, 10,179; Bauchi, 35,834; Bayelsa, 10,517; Benue, 21,070 ; Borno, 20,860; Cross River, 14,566; Delta, 20,580; Ebonyi, 8,587; Edo, 27,588; Ekiti, 27,739; Enugu, 11,131; FCT, 44,815; Gombe, 26,879; Imo, 18,954; Jigawa, 27,772; Kaduna, 55,756; Kano, 55,165; Katsina, 39,313; Kebbi, 15,597 and Kogi, 5,952

Others are: Kwara, 30,738; Lagos, 193,794; Nasarawa, 30,738 ; Niger, 26,712; Ogun, 52,613; Ondo, 31,406; Osun, 20,973; Oyo, 35,060; Plateau, 27,656; Rivers, 26,847; Sokoto, 11,608; Taraba, 7,714; Yobe, 21,037and Zamfara, 15,331.

Nigeria is currently leading 13 other African countries in the number Covax vaccine deployment with 3.94 million doses of Astrazeneca vaccines.

Following the vaccination of 1,051,096 persons, the country now has 2,888,904 and when added to the 100,000 doses of Astrazeneca recently donated to Nigeria by the Indian government, the total number of vaccines yet to utilised would be 2,988,904.

Copyright This Day. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about ASTRAZENECA PLC
05/15ASTRAZENECA  : Family doctors say they can answer vaccine questions, after Trude..
AQ
05/15ASTRAZENECA  : India hopes COVID-19 cases stabilising even as daily deaths stay ..
RE
05/14Taiwan tightens curbs after surge in domestic COVID-19 cases
RE
05/14ASTRAZENECA  : Experts call on Canada to use COVAX doses of AstraZeneca or give ..
AQ
05/14ASTRAZENECA  : You Want It When?! EU Sues AstraZeneca Over Vaccine Delivery Dela..
AQ
05/14ASTRAZENECA  : Angola Calls for Equity in Vaccine Distribution
AQ
05/14ASTRAZENECA  : Egypt receives second shipment of 1.77 million COVID-19 vaccines ..
AQ
05/14ASTRAZENECA  : Egypt receives second shipment of 1.77 million COVID-19 vaccines ..
AQ
05/14ASTRAZENECA  : Italy audit court rejects public funding for ReiThera COVID-19 va..
RE
05/14ASTRAZENECA  : Italy audit court rejects public funding for ReiThera COVID-19 va..
RE
More news
Financials (USD)
Sales 2021 31 426 M - -
Net income 2021 4 488 M - -
Net Debt 2021 10 883 M - -
P/E ratio 2021 32,7x
Yield 2021 2,57%
Capitalization 145 B 145 B -
EV / Sales 2021 4,98x
EV / Sales 2022 4,36x
Nbr of Employees 76 100
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 130,45 $
Last Close Price 110,83 $
Spread / Highest target 49,7%
Spread / Average Target 17,7%
Spread / Lowest Target -13,2%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC7.37%145 472
JOHNSON & JOHNSON8.16%448 257
ROCHE HOLDING AG-1.80%290 657
PFIZER, INC.8.94%224 020
ABBVIE INC.8.66%205 641
NOVARTIS AG-3.78%200 099